Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
20,860,674
-
Share change
-
-197,580
-
Total reported value
-
$201,445,609
-
Put/Call ratio
-
22%
-
Price per share
-
$9.66
-
Number of holders
-
64
-
Value change
-
-$1,634,265
-
Number of buys
-
29
-
Number of sells
-
28
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q1 2016
As of 31 Mar 2016,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,860,674 shares.
The largest 10 holders included
FMR LLC, Capital Research Global Investors, Versant Venture Management, LLC, Capital World Investors, SV Life Sciences Advisers, LLC, FEDERATED INVESTORS INC /PA/, JENNISON ASSOCIATES LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, and BlackRock Fund Advisors.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.